Retrieve available abstracts of 198 articles: HTML format
Single Articles
July 2025
CHAN NJ, Chen YY, Hsu CC, Lin YS, et al Sensitizing effect of antimigraine drug sumatriptan on capsaicin-sensitive lung
vagal neurons via 5-HT(1B/1D) receptors and PKA: Relevance to adverse chest
effects.
Cephalalgia. 2025;45:3331024251355949. PubMedAbstract available
ROMOZZI M, Scipioni L, Di Tella S, Silveri MC, et al Genetic characterization of the endocannabinoid system and psychiatric features
in patients with migraine and medication overuse headache.
Cephalalgia. 2025;45:3331024251314460. PubMedAbstract available
NIDDAM DM, Lai KL, Hsiao YT, Wang YF, et al Grey-matter network topology in migraine with aura.
Cephalalgia. 2025;45:3331024251353146. PubMedAbstract available
June 2025
CHAUDHRY BA, Younis S, Messina R, Garcia-Azorin D, et al Cortical thickness studies in migraine: Current evidence and future directions.
Cephalalgia. 2025;45:3331024251341204. PubMedAbstract available
SILVESTRO M, Orologio I, Sozio P, Dortucci V, et al No additional benefit with detoxification strategies: A real world experience in
200 patients with chronic migraine and either simple or complex MOH treated with
CGRP monoclonal antibodies.
Cephalalgia. 2025;45:3331024251329808. PubMedAbstract available
JAIMES A, Rodriguez-Vico J, Pajares O, Eguilior Caffarena I, et al Retrospective cohort study of anti-CGRP monoclonal antibody unresponsive migraine
individuals treated with atogepant: The RESCUE study.
Cephalalgia. 2025;45:3331024251346925. PubMedAbstract available
ASHINA S, Kim G, Muenzel EJ, Buse DC, et al Patterns of calcitonin gene-related peptide monoclonal antibody use in people
with migraine: Results of the OVERCOME (US) study.
Cephalalgia. 2025;45:3331024251341243. PubMedAbstract available
WENNERSTEN T, Lindh JD, Nilsson Remahl AIM, Andersson ML, et al Higher socioeconomic status is associated with dispensation of monoclonal
antibodies against calcitonin gene-related peptide in migraine: A nested
case-control study.
Cephalalgia. 2025;45:3331024251348648. PubMedAbstract available
LING YH, Pan LH, Chen SP, Chen WT, et al Comorbidity with fibromyalgia predicted poorer outcomes in patients with chronic
migraine on flunarizine: Prospective proof-of-concept study.
Cephalalgia. 2025;45:3331024251353412. PubMedAbstract available
May 2025
WONG HT, Khan R, Buture A, Khalil M, et al OnabotulinumtoxinA treatment for chronic migraine in pregnancy: An updated report
of real-world headache and pregnancy outcomes over 14 years in Hull.
Cephalalgia. 2025;45:3331024251327387. PubMedAbstract available
EMMENEGGER MJ, Gantenbein AR Philosophical aspects of migraine: Headache treatment is a human-to-human
service.
Cephalalgia. 2025;45:3331024251343225. PubMedAbstract available
SORRENTINO A, Di Lorenzo C Comment on: Setting higher standards for migraine prevention: A position
statement of the International Headache Society.
Cephalalgia. 2025;45:3331024251343217. PubMed
GOZALOV E, Karlsson WK, Christensen RH, Al-Khazali HM, et al Serum GFAP and NfL levels in migraine: A registry for migraine (REFORM) study.
Cephalalgia. 2025;45:3331024251338178. PubMedAbstract available
PORRECA F, Navratilova E, Dodick DW Advancing understanding of migraine pathophysiology and therapy by consideration
of patient sex.
Cephalalgia. 2025;45:3331024251339466. PubMedAbstract available
MORENO-AJONA D, Gosalia H, Hoffmann J, Goadsby PJ, et al Amylin and the amylin receptors in migraine: Is there another pathway to target?
Cephalalgia. 2025;45:3331024251340066. PubMedAbstract available
RUSSO A, Reuter U Raising the bar in migraine prevention: Toward freedom and optimal control.
Cephalalgia. 2025;45:3331024251331198. PubMed
ORNELLO R, D'Atri A, De Icco R, De Santis F, et al Effectiveness of transcranial direct current stimulation and monoclonal
antibodies acting on the CGRP as a combined treatment for migraine (TACTIC):
Results of a randomized controlled trial.
Cephalalgia. 2025;45:3331024251325567. PubMedAbstract available
GOLLION C, Ashina H, Hackert Christensen R, Al-Khazali HM, et al Intact white matter in adults with migraine: A REFORM MRI study.
Cephalalgia. 2025;45:3331024251339423. PubMedAbstract available
April 2025
PENSATO U, Cevoli S, Pierangeli G, Cortelli P, et al Reply to "What is the evolutionary disadvantage of migraine?".
Cephalalgia. 2025;45:3331024251327377. PubMed
LISICKI M, Schoenen J What is the evolutionary disadvantage of migraine?
Cephalalgia. 2025;45:3331024251327361. PubMed
MAS-DE-LES-VALLS R, Gomez-Dabo L, Caronna E, Gallardo VJ, et al Effectiveness of anti-CGRP monoclonal antibodies and onabotulinumtoxinA in
menstrually-related migraine: The unmet need of perimenstrual headache days.
Cephalalgia. 2025;45:3331024251332519. PubMedAbstract available
VALENCA MM, Szewczyk AK Stroke-like migraine attacks after radiation therapy (SMART) syndrome: A call for
standardized diagnostic criteria.
Cephalalgia. 2025;45:3331024251334355. PubMed
ROBBLEE J Rethinking status migrainosus: Escalation shouldn't wait for 72 hours.
Cephalalgia. 2025;45:3331024251334137. PubMed
VERNIERI F, Iannone LF, Lo Castro F, Sebastianelli G, et al Effectiveness and tolerability of atogepant in the prevention of migraine: A real
life, prospective, multicentric study (the STAR study).
Cephalalgia. 2025;45:3331024251335927. PubMedAbstract available
HAGHDOOST F Internet and social media's role in migraine education: Headache or not headache?
Cephalalgia. 2025;45:3331024251336152. PubMed
AL-KHAZALI HM, Christensen RH, Ashina H Clinical comparisons between post-traumatic headache and migraine: A
cross-sectional study.
Cephalalgia. 2025;45:3331024251331605. PubMedAbstract available
GONZALEZ-MARTINEZ A, Wei DY, Karsan N, Nagaraj K, et al Evaluation of premonitory spontaneous and nitroglycerin triggered symptoms among
patients with cluster headache and migraine.
Cephalalgia. 2025;45:3331024251331554. PubMedAbstract available
MESSINA R, Chong CD Migraine and the white matter microstructure controversy: Time for a
methodological reset?
Cephalalgia. 2025;45:3331024251339431. PubMed
SEBASTIANELLI G The 'theory of everything' for migraine pathophysiology will never exist:
Insights from glial cells.
Cephalalgia. 2025;45:3331024251338171. PubMed
ORNELLO R, Caponnetto V, Ahmed F, Al-Khazali HM, et al Evidence-based guidelines for the pharmacological treatment of migraine, summary
version.
Cephalalgia. 2025;45:3331024251321500. PubMedAbstract available
ORNELLO R, Caponnetto V, Ahmed F, Al-Khazali HM, et al Evidence-based guidelines for the pharmacological treatment of migraine.
Cephalalgia. 2025;45:3331024241305381. PubMedAbstract available
March 2025
OMLAND PM, Hansen JO, Neverdahl JP, Mykland MS, et al Migraine and insufficient sleep: The effect of sleep restriction on nociceptive
evoked potentials in migraine.
Cephalalgia. 2025;45:3331024251329400. PubMedAbstract available
PULEDDA F, Tassorelli C Reply to "Reassessing partial efficacy or not responding to acute migraine
treatment".
Cephalalgia. 2025;45:3331024251325543. PubMed
POZO-ROSICH P, van Veelen N, Caronna E, Vaghi G, et al Guidelines of the International Headache Society for Real-World Evidence studies
in migraine and cluster headache.
Cephalalgia. 2025;45:3331024251318016. PubMedAbstract available
YANG L, Jin T, Wang H Reassessing partial efficacy or not responding to acute migraine treatment.
Cephalalgia. 2025;45:3331024251325526. PubMed
BAI Y, Chu MK, Kang JJ, Chae J, et al No change in interictal plasma and salivary CGRP levels in individuals with
vestibular migraine corresponding to episodic migraine.
Cephalalgia. 2025;45:3331024251322418. PubMedAbstract available
February 2025
GUZMAN G, Kopruszinski CM, Barber KR, Lillo Vizin RC, et al Chronification of migraine sensitizes to CGRP in male and female mice.
Cephalalgia. 2025;45:3331024251317446. PubMedAbstract available
CHEEMA S, Lagrata S, Rantell KR, Ahmed M, et al OnabotulinumtoxinA for primary new daily persistent headache and comparison to
chronic migraine.
Cephalalgia. 2025;45:3331024251317448. PubMedAbstract available
GANTENBEIN AR Depression screening in migraine - A double-edged sword.
Cephalalgia. 2025;45:3331024251317606. PubMed
GOADSBY PJ, Jurgens TP, Brand-Schieber E, Nagy K, et al Efficacy of ubrogepant and atogepant in males and females with migraine: A
secondary analysis of randomized clinical trials.
Cephalalgia. 2025;45:3331024251320610. PubMedAbstract available
SACCO S, Ashina M, Diener HC, Haghdoost F, et al Setting higher standards for migraine prevention: A position statement of the
International Headache Society.
Cephalalgia. 2025;45:3331024251320608. PubMedAbstract available
ASHEER J, Ali F, Hilker R, Videbech P, et al Methodological challenges in using screening tools for depression in migraine: A
systematic review.
Cephalalgia. 2025;45:3331024251317635. PubMedAbstract available
SZABO E, Bolo NR, Borsook D, Burstein R, et al Peripherally acting anti-CGRP monoclonal antibodies attenuate cortical
resting-state connectivity in migraine patients.
Cephalalgia. 2025;45:3331024241313377. PubMedAbstract available
LIAO YH, Tzeng YS, Chen SP, Ling YH, et al Association between headache frequency and risk for fibromyalgia in patients with
migraine.
Cephalalgia. 2025;45:3331024251317486. PubMedAbstract available
ZORRILLA E, Krivoshein G, Kuburas A, Schenke M, et al Combined effects of cannabidiol and Delta9-tetrahydrocannabinol alleviate
migraine-like symptoms in mice.
Cephalalgia. 2025;45:3331024251314487. PubMedAbstract available
January 2025
STAEHR C, Nyegaard M, Bach FW, Rohde PD, et al Exploring the association between familial hemiplegic migraine genes (CACNA1A,
ATP1A2 and SCN1A) with migraine and epilepsy: A UK Biobank exome-wide association
study.
Cephalalgia. 2025;45:3331024241306103. PubMedAbstract available
MOHAMMAD S, Bussu G, Rukh G, Schioth HB, et al Migraine and its major subtypes - with and without aura are associated with
polygenic scores for autism.
Cephalalgia. 2025;45:3331024241312666. PubMedAbstract available
LEE GJ, Hode V, Georgieva T, Rau J, et al Prolactin-induced sensitization of trigeminal nociceptors promotes migraine
co-morbidity in endometriosis.
Cephalalgia. 2025;45:3331024241313378. PubMedAbstract available
VAN DER AREND BWH, van Welie FC, Olsen MH, Versijpt J, et al Impact of CGRP monoclonal antibody treatment on blood pressure in patients with
migraine: A systematic review and potential clinical implications.
Cephalalgia. 2025;45:3331024241297673. PubMedAbstract available
December 2024
GENDOLLA A, Brown JD, Mercadante AR, Drakeley S, et al The incremental burden and healthcare resource utilization among people with
migraine in Europe: Insights from the 2020 European National Health and Wellness
Survey.
Cephalalgia. 2024;44:3331024241276415. PubMedAbstract available
Abstracts of the 20(th) Biennial Migraine Trust International Symposium, London
UK, 5th to 8th September 2024.
Cephalalgia. 2024;44:3331024241280496. PubMed
OLESEN J, Tfelt-Hansen P Methodology of drug trials in migraine: History and suggestions for the future.
Cephalalgia. 2024;44:3331024241298642. PubMedAbstract available
ROMOZZI M, Lokhandwala A, Vollono C, Vigani G, et al An evolving machine-learning-based algorithm to early predict response to
anti-CGRP monoclonal antibodies in patients with migraine.
Cephalalgia. 2024;44:3331024241262751. PubMedAbstract available
PETERLIN BL, Bond DS, Ailani J, Dodick DW, et al Weight loss with atogepant during the preventive treatment of migraine: A pooled
analysis.
Cephalalgia. 2024;44:3331024241299753. PubMedAbstract available
GOTTSCHALK C, Gandhi P, Pozo-Rosich P, Christie S, et al Effect of preventive treatment with atogepant on quality of life, daily
functioning, and headache impact across the spectrum of migraine: Findings from
three double-blind, randomized, phase 3 trials.
Cephalalgia. 2024;44:3331024241300305. PubMedAbstract available
November 2024
BURGALASSI A, Romozzi M, Vigani G, De Icco R, et al Outcomes, unmet needs, and challenges in the management of patients who withdraw
from anti-CGRP monoclonal antibodies: A prospective cohort study.
Cephalalgia. 2024;44:3331024241273968. PubMedAbstract available
SACCO S, De Santis F, Onofri A, Rosignoli C, et al A call for academic pragmatic clinical trials to address open questions in
migraine prevention.
Cephalalgia. 2024;44:3331024241291574. PubMedAbstract available
CLOET F, Gueyraud G, Lerebours F, Munio M, et al Stroke due to small-vessel disease and migraine: A case-control study of a young
adult with ischemic stroke population.
Cephalalgia. 2024;44:3331024241282015. PubMedAbstract available
AILANI J, Lalla A, Halker Singh RB, Holle-Lee D, et al Benefit-risk assessment based on number needed to treat and number needed to
harm: Atogepant vs. calcitonin gene-related peptide monoclonal antibodies.
Cephalalgia. 2024;44:3331024241299377. PubMedAbstract available
PULEDDA F, de Boer I, Messina R, Garcia-Azorin D, et al Worldwide availability of medications for migraine and tension-type headache: A
survey of the International Headache Society.
Cephalalgia. 2024;44:3331024241297688. PubMedAbstract available
YANG C, Wei C, Alam S, Chen X, et al The neurotrophic factor artemin and its receptor GFRalpha3 mediate migraine-like pain
via the ion channel TRPM8.
Cephalalgia. 2024;44:3331024241297679. PubMedAbstract available
DALLA VOLTA G, Russo A, Silvestro M, Ornello R, et al Exploring the multifaceted characteristics of aura in migraine: A multicenter,
cross-sectional study.
Cephalalgia. 2024;44:3331024241299453. PubMedAbstract available
October 2024
SEBASTIANELLI G, Atalar AC, Cetta I, Farham F, et al Insights from triggers and prodromal symptoms on how migraine attacks start: The
threshold hypothesis.
Cephalalgia. 2024;44:3331024241287224. PubMedAbstract available
PELES I, Sharvit S, Zlotnik Y, Gordon M, et al Migraine and work - beyond absenteeism: Migraine severity and occupational
burnout - A cohort study.
Cephalalgia. 2024;44:3331024241289930. PubMedAbstract available
CAMMAROTA F, De Icco R, Vaghi G, Corrado M, et al High-frequency episodic migraine: Time for its recognition as a migraine subtype?
Cephalalgia. 2024;44:3331024241291578. PubMedAbstract available
TRILLER P, Blessing VN, Overeem LH, Fitzek MP, et al Efficacy of eptinezumab in non-responders to subcutaneous monoclonal antibodies
against CGRP and the CGRP receptor: A retrospective cohort study.
Cephalalgia. 2024;44:3331024241288875. PubMedAbstract available
September 2024
ACARSOY C, Ikram MK, Ikram MA, Vernooij MW, et al Migraine and brain structure in the elderly: The Rotterdam Study.
Cephalalgia. 2024;44:3331024241266951. PubMedAbstract available
KOPRUSZINSKI CM, Lee G, Martin LK, Barber KR, et al A male-specific mechanism of meningeal nociceptor sensitization promoting
migraine headache.
Cephalalgia. 2024;44:3331024241281493. PubMedAbstract available
PULEDDA F, Sacco S, Diener HC, Ashina M, et al International Headache Society Global Practice Recommendations for Preventive
Pharmacological Treatment of Migraine.
Cephalalgia. 2024;44:3331024241269735. PubMed
IHARA K, Casillo F, Dahshan A, Genc H, et al Are we closer to achieving precision medicine for migraine treatment? A narrative
review.
Cephalalgia. 2024;44:3331024241281518. PubMedAbstract available
MELO-CARRILLO A, Strassman AM, Malcolm KJ, Adams AM, et al Exploring the effects of extracranial injections of botulinum toxin type A on
activation and sensitization of central trigeminovascular neurons by cortical
spreading depression in male and female rats.
Cephalalgia. 2024;44:3331024241278919. PubMedAbstract available
WILCHA RJ, Goadsby PJ Triptan non-response in a London tertiary headache centre: What can we learn? A
retrospective study.
Cephalalgia. 2024;44:3331024241278911. PubMedAbstract available
CASILLO F, Di Renzo A, Sebastianelli G, Abagnale C, et al Lack of a direct link between macular cones function and photophobia in
interictal migraine.
Cephalalgia. 2024;44:3331024241276501. PubMedAbstract available
ASHINA M, Steiner TJ, Hansen JM, Hauberg DS, et al Cost of illness and labour market disaffiliation among patients with migraine
discontinuing triptan treatment: A Danish nationwide register study from 1995 to
2021.
Cephalalgia. 2024;44:3331024241269758. PubMedAbstract available
ERNSTSEN C, Obelitz-Ryom K, Kristensen DMB, Olesen J, et al Mechanisms of GTN-induced migraine: Role of NOS isoforms, sGC and peroxynitrite
in a migraine relevant mouse model.
Cephalalgia. 2024;44:3331024241277542. PubMedAbstract available
ELOSUA-BAYES I, Alpuente A, Melgarejo L, Caronna E, et al Case series on monoclonal antibodies targeting calcitonin gene-related peptide in
migraine patients during pregnancy: Enhancing safety data.
Cephalalgia. 2024;44:3331024241273966. PubMedAbstract available
August 2024
DO TP Clarification on the incidence and sex-specificity of sexual dysfunction as an
adverse event of CGRP-targeting medications.
Cephalalgia. 2024;44:3331024241268058. PubMed
OMLAND PM Enhanced learning in migraine: False positive finding or discovery of a new
migraine trait?
Cephalalgia. 2024;44:3331024241268297. PubMed
STUBBERUD A, Borkenhagen S, Oteiza F, Dueland AN, et al Patterns of migraine medication use in Norway: A nationwide registry-based
observational study.
Cephalalgia. 2024;44:3331024241268212. PubMedAbstract available
PULEDDA F, Sacco S, Diener HC, Ashina M, et al International Headache Society global practice recommendations for the acute
pharmacological treatment of migraine.
Cephalalgia. 2024;44:3331024241252666. PubMedAbstract available
KATSARAVA Z, Buse DC, Leroux E, Lanteri-Minet M, et al Disability in migraine: Multicountry results from the Chronic Migraine
Epidemiology and Outcomes - International (CaMEO-I) Study.
Cephalalgia. 2024;44:3331024241274343. PubMedAbstract available
SIMMONDS L, Jamtoy KA, Aschehoug I, Hara S, et al Open label experience of repeated OnabotulinumtoxinA injections towards the
sphenopalatine ganglion in patients with chronic cluster headache and chronic
migraine.
Cephalalgia. 2024;44:3331024241273967. PubMedAbstract available
THOMSEN AV, Al-Karagholi MA, Hougaard A, Ostrowski SR, et al Effects of levcromakalim in patients with migraine aura without headache: An
experimental study.
Cephalalgia. 2024;44:3331024241274366. PubMedAbstract available
HU YY, Souza R, Muthuraman A, Knapp L, et al Glucocorticoid signaling mediates stress-induced migraine-like behaviors in a
preclinical mouse model.
Cephalalgia. 2024;44:3331024241277941. PubMedAbstract available
MULLIN K, Croop R, Mosher L, Fullerton T, et al Long-term safety of zavegepant nasal spray for the acute treatment of migraine: A
phase 2/3 open-label study.
Cephalalgia. 2024;44:3331024241259456. PubMedAbstract available
AL-KHAZALI HM, Al-Sayegh Z, Younis S, Christensen RH, et al Systematic review and meta-analysis of Neck Disability Index and Numeric Pain
Rating Scale in patients with migraine and tension-type headache.
Cephalalgia. 2024;44:3331024241274266. PubMedAbstract available
PERES MFP, Sacco S, Pozo-Rosich P, Tassorelli C, et al Migraine is the most disabling neurological disease among children and
adolescents, and second after stroke among adults: A call to action.
Cephalalgia. 2024;44:3331024241267309. PubMedAbstract available
July 2024
RUSCHEWEYH R, Forderreuther S, Freilinger T, Gaul C, et al Minimal important difference of the Migraine Disability Assessment (MIDAS):
Longitudinal data from the DMKG Headache Registry.
Cephalalgia. 2024 Jul 21:3331024241261077. doi: 10.1177/03331024241261077. PubMedAbstract available
DE VRIES T, Boucherie DM, Chan KY, Rubio-Beltran E, et al Sex differences in CGRP-induced vasodilation of human middle meningeal arteries
but not human coronary arteries: implications for migraine.
Cephalalgia. 2024;44:3331024241254088. PubMedAbstract available
TOT K, Braunitzer G, Harcsa-Pinter N, Kiss A, et al Enhanced audiovisual associative pair learning in migraine without aura in adult
patients: An unexpected finding.
Cephalalgia. 2024;44:3331024241258722. PubMedAbstract available
June 2024
EXACOUSTOS C, Martire FG, Albanese M, Selntigia A, et al REPLY to Comment on Correlation between endometriosis and migraine features:
Results from a prospective case-control study'': Correlation between
endometriosis and migraine features is not based on a broad strokes results.
Cephalalgia. 2024;44:3331024241254821. PubMed
LIU L, Chen Q, Zhao L, Lyu T, et al Acupuncture plus topiramate placebo versus topiramate plus sham acupuncture for
the preventive treatment of chronic migraine: A single-blind, double-dummy,
randomized controlled trial.
Cephalalgia. 2024;44:3331024241261080. PubMedAbstract available
ISHII R, Ishizuchi K, Watanabe N, Fukazawa R, et al Efficacy and tolerability of 100 mg of lasmiditan for migraine: A multi-center,
prospective observational real-world study in Japan.
Cephalalgia. 2024;44:3331024241258695. PubMedAbstract available
AL-KHAZALI HM, Ashina H, Christensen RH, Wiggers A, et al Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with
erenumab.
Cephalalgia. 2024;44:3331024241258734. PubMedAbstract available
RAFFAELLI B, Do TP, Ashina H, Snellman J, et al Induction of cGMP-mediated migraine attacks is independent of CGRP receptor
activation.
Cephalalgia. 2024;44:3331024241259489. PubMedAbstract available
LI H, Xu X, Xu R, Fan PX, et al Latent class analysis of migraine associated vestibular-auditory symptoms.
Cephalalgia. 2024;44:3331024241262488. PubMedAbstract available
BRAILLON A Registry-based safety studies of migraine drugs in pregnancy: Acknowledging our
failures.
Cephalalgia. 2024;44:3331024241262486. PubMed
Corrigendum to "Evaluating the efficacy of CGRP mAbs and gepants for the
preventive treatment of migraine: A systematic review and network meta-analysis
of phase 3 randomised controlled trials".
Cephalalgia. 2024;44:3331024241255216. PubMed
Corrigendum to: Evaluation of outcomes of calcitonin gene-related peptide
(CGRP)-targeting therapies for acute and preventive migraine treatment based on
patient sex.
Cephalalgia. 2024;44:3331024241254952. PubMed
May 2024
RASMUSSEN AV, Jensen RH, Gantenbein A, Sumelahti ML, et al Consensus recommendations on the role of nurses in headache care: A European
e-Delphi study.
Cephalalgia. 2024;44:3331024241252161. PubMedAbstract available
KOKOTI L, Al-Karagholi MA, Zhuang ZA, Amirguliyev S, et al Non-vascular ATP-sensitive potassium channel activation does not trigger migraine
attacks: A randomized clinical trial.
Cephalalgia. 2024;44:3331024241248211. PubMedAbstract available
AKGOR U, Ince O Comment on ''Correlation between endometriosis and migraine features: Results
from a prospective case-control study''.
Cephalalgia. 2024;44:3331024241254824. PubMed
GIRI S, Tronvik E, Dalen H, Ellekjaer H, et al Migraine and risk of atrial fibrillation: A 9-year follow-up based on the
Trondelag Health Study.
Cephalalgia. 2024;44:3331024241254517. PubMedAbstract available
AL-HASSANY L, Boucherie DM, Couturier EGM, MaassenVanDenBrink A, et al Case reports: Could sexual dysfunction in women with migraine be a side effect of
CGRP inhibition?
Cephalalgia. 2024;44:3331024241248837. PubMedAbstract available
April 2024
RATTANAWONG W, Rapoport A, Srikiatkhachorn A Medication "underuse" headache.
Cephalalgia. 2024;44:3331024241245658. PubMedAbstract available
MITTER VR, Lupattelli A, Bjork MH, Nordeng HME, et al Identification and characterization of migraine in pregnancy: A Norwegian
registry-based cohort study.
Cephalalgia. 2024;44:3331024241248846. PubMedAbstract available
GARCIA-AZORIN D, Martinez-Badillo C, Camina Muniz J, Gago-Veiga AB, et al CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability
study in migraine.
Cephalalgia. 2024;44:3331024241248833. PubMedAbstract available
WHITAKER DJ, Dumkrieger GM, Hentz JG, Dodick DW, et al Physical impairment during and between migraine attacks: A daily diary study of
patients with chronic migraine.
Cephalalgia. 2024;44:3331024241249747. PubMedAbstract available
CROOP R, Berman G, Kudrow D, Mullin K, et al A multicenter, open-label long-term safety study of rimegepant for the acute
treatment of migraine.
Cephalalgia. 2024;44:3331024241232944. PubMedAbstract available
OLFAT M, Hosseinpour S, Masoumi S, Gogia Rastogi R, et al A comparative study on prophylactic efficacy of cinnarizine and amitriptyline in
childhood migraine: a randomized double-blind clinical trial.
Cephalalgia. 2024;44:3331024241230963. PubMedAbstract available
March 2024
PASCUAL-MATO M, Garate G, de Prado-Tejerina C, Garcia MJ, et al Increased prevalence of migraine in women with inflammatory bowel disease: A
cross-sectional study.
Cephalalgia. 2024;44:3331024241233979. PubMedAbstract available
SELNTIGIA A, Exacoustos C, Ortoleva C, Russo C, et al Correlation between endometriosis and migraine features: Results from a
prospective case-control study.
Cephalalgia. 2024;44:3331024241235210. PubMedAbstract available
PORRECA F, Navratilova E, Hirman J, van den Brink AM, et al Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting
therapies for acute and preventive migraine treatment based on patient sex.
Cephalalgia. 2024;44:3331024241238153. PubMedAbstract available
THOMSEN AV, Al-Karagholi MA, Hougaard A, Ostrowski SR, et al Investigations of the migraine-provoking effect of levcromakalim in patients with
migraine with aura.
Cephalalgia. 2024;44:3331024241237247. PubMedAbstract available
LAMAS PEREZ R, Millan-Vazquez M, Gonzalez-Oria C Efficacy and safety of galcanezumab as chronic cluster headache preventive
treatment under real world conditions: Observational prospective study.
Cephalalgia. 2024;44:3331024231226181. PubMedAbstract available
SACCO S, Porreca F Breaking barriers in migraine care: Advancing gender medicine to bridge the gap
for men.
Cephalalgia. 2024;44:3331024241238157. PubMed
DIENER HC, May A New migraine drugs: A critical appraisal of the reason why the majority of
migraine patients do not receive an adequate medication.
Cephalalgia. 2024;44:3331024241228605. PubMedAbstract available
ASHINA H, Diener HC, Tassorelli C, Scher AI, et al Guidelines of the International Headache Society for controlled trials of
pharmacological preventive treatment for persistent post-traumatic headache
attributed to mild traumatic brain injury.
Cephalalgia. 2024;44:3331024241234068. PubMedAbstract available
February 2024
TORRES-FERRUS M, Gallardo VJ, Alpuente A, Caronna E, et al Improvement of migraine depressive symptoms is not related to headache frequency:
exploring the impact of anti-CGRP therapies.
Cephalalgia. 2024;44:3331024231222923. PubMedAbstract available
THURAIAIYAH J, Ashina H, Christensen RH, Al-Khazali HM, et al Premonitory symptoms in migraine: A REFORM Study.
Cephalalgia. 2024;44:3331024231223979. PubMedAbstract available
PHILLIPS K, Clerkin-Oliver C, Nirantharakumar K, Crowe FL, et al How migraine and its associated treatment impact on pregnancy outcomes: Umbrella
review with updated systematic review and meta-analysis.
Cephalalgia. 2024;44:3331024241229410. PubMedAbstract available
VIANA M, Hougaard A, Tronvik E, Winnberg IG, et al Visual migraine aura iconography: A multicentre, cross-sectional study of
individuals with migraine with aura.
Cephalalgia. 2024;44:3331024241234809. PubMedAbstract available
IKUMI N, Marti-Marca A, Torre-Sune A, Cerda-Company X, et al Quantifying sensory thresholds along the migraine cycle: An exploratory
longitudinal study.
Cephalalgia. 2024;44:3331024241230279. PubMedAbstract available
TASSORELLI C, Onishchenko K, Halker Singh RB, Duan M, et al Comparative efficacy, quality of life, safety, and tolerability of atogepant and
rimegepant in migraine prevention: A matching-adjusted indirect comparison
analysis.
Cephalalgia. 2024;44:3331024241235156. PubMedAbstract available
SHEWALE AR, Brandenburg JA, Burslem K, Lipton RB, et al Health care resource utilization and costs associated with diagnosed medication
overuse headache and potential acute medication overuse in individuals with
migraine.
Cephalalgia. 2024;44:3331024241235139. PubMedAbstract available
January 2024
COPPOLA G, Renzo AD, Parisi V, Serrao M, et al Comment on "Lack of reproducibility of resting-state functional MRI findings in
migraine with aura".
Cephalalgia. 2024;44:3331024231225186. PubMed
PICO MJ, Badri M, Michalak N, Siefferman JW, et al Systemic allergic reaction to galcanezumab (emgality): a case report.
Cephalalgia. 2024;44:3331024231222914. PubMedAbstract available
NIDDAM DM, Lai KL, Hsiao YT, Wang YF, et al Grey matter structure within the visual networks in migraine with aura:
multivariate and univariate analyses.
Cephalalgia. 2024;44:3331024231222637. PubMedAbstract available
BUGGE NS, Grotta Vetvik K, Alstadhaug KB, Braaten T, et al Cumulative exposure to estrogen may increase the risk of migraine in women.
Cephalalgia. 2024;44:3331024231225972. PubMedAbstract available
FLORESCU AM, Lannov LV, Younis S, Cullum CK, et al No wearing-off effect of erenumab or fremanezumab for chronic migraine
prevention: a single-center, real-world, observational study.
Cephalalgia. 2024;44:3331024231222915. PubMedAbstract available
RAFFAELLI B, Do TP, Chaudhry BA, Amin FM, et al Activation of ATP-sensitive potassium channels triggers migraine attacks
independent of calcitonin gene-related peptide receptors: a randomized
placebo-controlled trial.
Cephalalgia. 2024;44:3331024231222916. PubMedAbstract available
MONTE G, Papetti L, Ursitti F, Sforza G, et al Childhood primary stabbing headache: A double center study.
Cephalalgia. 2024;44:3331024231225974. PubMedAbstract available
KRISTOFFERSEN ES, Pallesen S, Waage S, Bjorvatn B, et al The long-term effect of work schedule, shift work disorder, insomnia and restless
legs syndrome on headache among nurses: A prospective longitudinal cohort study.
Cephalalgia. 2024;44:3331024231226323. PubMedAbstract available
December 2023
BASEDAU H, Ornello R, Matteis E, Davaasuren B, et al Placebo and nocebo in the treatment of migraine: How much does real world
effectiveness depend on contextual effects?
Cephalalgia. 2023;43:3331024231218392. PubMedAbstract available
PENSATO U, Cevoli S, Pierangeli G, Cortelli P, et al The evolutionary meaning of migraine.
Cephalalgia. 2023;43:3331024231209303. PubMedAbstract available
TEZUKA T, Shibata M, Hanaoka H, Izawa Y, et al Systemic lupus erythematosus mimicking retinal migraine: a case report.
Cephalalgia. 2023;43:3331024231219477. PubMedAbstract available
DOBOS D, Kokonyei G, Gyebnar G, Szabo E, et al Microstructural differences in migraine: A diffusion-tensor imaging study.
Cephalalgia. 2023;43:3331024231216456. PubMedAbstract available
AL-KARAGHOLI MA Targeting CGRP pathways and aura: A peripheral site with a central effect.
Cephalalgia. 2023;43:3331024231212895. PubMedAbstract available
CHRISTOPHERSEN P, Dyhring T The shortcoming of using glibenclamide in exploratory clinical headache
provocation studies.
Cephalalgia. 2023;43:3331024231219475. PubMedAbstract available
November 2023
VAN DER AREND B, Terwindt GM Response to Letter to the Editor, Comment on "Effect of COVID vaccinations on
monthly migraine days".
Cephalalgia. 2023;43:3331024231208123. PubMed
DAUNGSUPAWONG H, Wiwanitkit V Comment on "Effect of COVID vaccination on monthly migraine days".
Cephalalgia. 2023;43:3331024231208121. PubMed
AL-KHAZALI HM, Christensen RH, Dodick DW, Chaudhry BA, et al Hypersensitivity to opening of ATP-sensitive potassium channels in post-traumatic
headache.
Cephalalgia. 2023;43:3331024231210930. PubMedAbstract available
NAVARRO-PEREZ MP, Santos-Lasaosa S, Olesen J Evaluation of the ICHD-3 diagnostic criteria for cardiac cephalalgia and new
proposal.
Cephalalgia. 2023;43:3331024231202243. PubMedAbstract available
HOUGAARD A, Gaist D, Garde E, Iversen P, et al Lack of reproducibility of resting-state functional MRI findings in migraine with
aura.
Cephalalgia. 2023;43:3331024231212574. PubMedAbstract available
BAHRA A Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology,
clinical features and treatment.
Cephalalgia. 2023;43:3331024231214239. PubMedAbstract available
GARCIA-AZORIN D, Santana-Lopez L, Lozano-Alonso JE, Ordax-Diez A, et al InfluenCEF study: Clinical phenotype and duration of headache attributed to
influenza infection.
Cephalalgia. 2023;43:3331024231212900. PubMedAbstract available
ASHINA M, Mitsikostas DD, Amin FM, Kokturk P, et al Real-world effectiveness of fremanezumab for the preventive treatment of
migraine: Interim analysis of the pan-European, prospective, observational, phase
4 PEARL study.
Cephalalgia. 2023;43:3331024231214987. PubMedAbstract available
October 2023
SEBASTIANELLI G, Casillo F, Abagnale C, Renzo AD, et al Central sensitization mechanisms in chronic migraine with medication overuse
headache: a study of thalamocortical activation and lateral cortical inhibition.
Cephalalgia. 2023;43:3331024231202240. PubMedAbstract available
AL-KHAZALI HM, Ashina H, Christensen RH, Wiggers A, et al An exploratory analysis of clinical and sociodemographic factors in CGRP-induced
migraine attacks: A REFORM study.
Cephalalgia. 2023;43:3331024231206375. PubMedAbstract available
DEV P, Favas TT, Jaiswal R, Cyriac M, et al The effect of low dose thyroid replacement therapy in patients with episodic
migraine and subclinical hypothyroidism: A randomised placebo-controlled trial.
Cephalalgia. 2023;43:3331024231182684. PubMedAbstract available
CHUANG CH, Li JY, King JT, Chen WT, et al Abnormal heart rate variability and its application in predicting treatment
efficacy in patients with chronic migraine: An exploratory study.
Cephalalgia. 2023;43:3331024231206781. PubMedAbstract available
CHRISTENSEN RH, Eigenbrodt AK, Ashina H, Steiner TJ, et al What proportion of people with migraine report postdromal symptoms? A systematic
review and meta-analysis of observational studies.
Cephalalgia. 2023;43:3331024231206376. PubMedAbstract available
KUAN AS, Chen SP, Wang YF, Wang SJ, et al Prolonged headache with vaccine- and dose-specific headache pattern associated
with vaccine against SARS-CoV-2 in patients with migraine.
Cephalalgia. 2023;43:3331024231208110. PubMedAbstract available
ZLOOF Y, Tsur AM, Simchoni M, Derazne E, et al Body mass index and migraine in adolescence: A nationwide study.
Cephalalgia. 2023;43:3331024231209309. PubMedAbstract available
ALEKSOVSKA K, Hershey AD, Deen M, Icco R, et al Efficacy and safety of monoclonal antibodies targeting CGRP in migraine
prevention. GRADE tables elaborated by the ad hoc working group of the
International Headache Society.
Cephalalgia. 2023;43:3331024231206162. PubMedAbstract available
BELIN AC, Barloese MC The genetics and chronobiology of cluster headache.
Cephalalgia. 2023;43:3331024231208126. PubMedAbstract available
September 2023
VAN DER AREND BWH, Bloemhof MM, van der Schoor AG, van Zwet EW, et al Effect of COVID vaccination on monthly migraine days: a longitudinal cohort
study.
Cephalalgia. 2023;43:3331024231198792. PubMedAbstract available
August 2023
ALPUENTE A, Torre-Sune A, Caronna E, Gine-Cipres E, et al Impact of anti-CGRP monoclonal antibodies on migraine attack accompanying
symptoms: A real-world evidence study.
Cephalalgia. 2023;43:3331024231177636. PubMedAbstract available
LA ROCCA M, Laporta A, Clemente L, Ammendola E, et al Galcanezumab treatment changes visual related EEG connectivity patterns in
migraine patients.
Cephalalgia. 2023;43:3331024231189751. PubMedAbstract available
ADAM I, Elmugabil A, AlHabardi N History of maternal migraine and its association with preeclampsia: A
case-control study in a low-resource setting in Sudan, Africa.
Cephalalgia. 2023;43:3000605231193823. PubMedAbstract available
PULEDDA F, Vigano A, Sebastianelli G, Parisi V, et al Electrophysiological findings in migraine may reflect abnormal synaptic
plasticity mechanisms: A narrative review.
Cephalalgia. 2023;43:3331024231195780. PubMedAbstract available
LIPTON RB, Halker Singh RB, Mechtler L, McVige J, et al Patient-reported migraine-specific quality of life, activity impairment and
headache impact with once-daily atogepant for preventive treatment of migraine in
a randomized, 52-week trial.
Cephalalgia. 2023;51:3331024231190296. PubMedAbstract available
July 2023
PATTERSON GENTILE C, Aguirre GK, Hershey AD, Szperka CL, et al Symptoms associated with headache in youth.
Cephalalgia. 2023;43:3331024231187162. PubMedAbstract available
June 2023
VERHAGEN IE, van der Arend BW, van Casteren DS, Thiermann NJ, et al Migraine with and without aura in relation to the menstrual cycle and other
hormonal milestones: A prospective cohort study.
Cephalalgia. 2023;43:3331024231164322. PubMedAbstract available
PELZER N, de Boer I, van den Maagdenberg AMJM, Terwindt GM, et al Neurological and psychiatric comorbidities of migraine: Concepts and future
perspectives.
Cephalalgia. 2023;43:3331024231180564. PubMedAbstract available
KLAN T, Gaul C, Liesering-Latta E, Witthoft M, et al Behavioral treatment for migraine prophylaxis in adults: Moderator analysis of a
randomized controlled trial.
Cephalalgia. 2023;43:3331024231178237. PubMedAbstract available
BERTZ R, Bhardwaj R, Morris BA, Ashbrenner E, et al A placebo-controlled, randomized, single and multiple dose study to evaluate the
safety, tolerability, and pharmacokinetics of rimegepant in healthy participants.
Cephalalgia. 2023;43:3331024231179131. PubMedAbstract available
BUTURE A, Tomkins EM, Shukralla A, Troy E, et al Two-year, real-world erenumab persistence and quality of life data in 82 pooled
patients with abrupt onset, unremitting, treatment refractory headache and a
migraine phenotype: New daily persistent headache or persistent post-traumatic
headache in the
Cephalalgia. 2023;43:3331024231182126. PubMedAbstract available
ADAMS AM, Buse DC, Leroux E, Lanteri-Minet M, et al Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study:
Methods and multi-country baseline findings for diagnosis rates and care.
Cephalalgia. 2023;43:3331024231180611. PubMedAbstract available
CARCEL C, Haghdoost F, Shen J, Nanda P, et al The effect of blood pressure lowering medications on the prevention of episodic
migraine: A systematic review and meta-analysis.
Cephalalgia. 2023;43:3331024231183166. PubMedAbstract available
THOMSEN AV, Puonti O, Gaist D, Kyvik KO, et al Investigations of the subarachnoid space as a potential link between aura and
headache in migraine: A case-control MRI study.
Cephalalgia. 2023;43:3331024231170541. PubMedAbstract available
CONSTANTINIDIS TS, Arvaniti C, Fakas N, Rudolf J, et al The prevalence and burden of medication overuse headache in Greece.
Cephalalgia. 2023;43:3331024231184909. PubMedAbstract available
May 2023
VAN DER AREND BWH, Verhagen IE, van Leeuwen M, van der Arend MQTP, et al Defining migraine days, based on longitudinal E-diary data.
Cephalalgia. 2023;43:3331024231166625. PubMedAbstract available
CHEEMA S, Mehta D, Ray JC, Hutton EJ, et al New daily persistent headache: A systematic review and meta-analysis.
Cephalalgia. 2023;43:3331024231168089. PubMedAbstract available
STUBBERUD A, Ingvaldsen SH, Brenner E, Winnberg I, et al Forecasting migraine with machine learning based on mobile phone diary and
wearable data.
Cephalalgia. 2023;43:3331024231169244. PubMedAbstract available
ASHINA M, Lanteri-Minet M, Ettrup A, Christoffersen CL, et al Efficacy and safety of eptinezumab for migraine prevention in patients with prior
preventive treatment failures: subgroup analysis of the randomized,
placebo-controlled DELIVER study.
Cephalalgia. 2023;43:3331024231170807. PubMedAbstract available
VAN WELIE RF, van Welie FC, de Vries Lentsch S, Dahan A, et al Characterizing opioid use in a Dutch cohort with migraine.
Cephalalgia. 2023;43:3331024231174160. PubMedAbstract available
HSIAO FJ, Chen WT, Wang YF, Chen SP, et al Identification of patients with chronic migraine by using sensory-evoked
oscillations from the electroencephalogram classifier.
Cephalalgia. 2023;43:3331024231176074. PubMedAbstract available
GULDIKEN YC, Petropoulos IN, Malik A, Malik RA, et al Corneal confocal microscopy identifies corneal nerve fiber loss in patients with
migraine.
Cephalalgia. 2023;43:3331024231170810. PubMedAbstract available
RUSCHEWEYH R, Dresler T, Forderreuther S, Gaul C, et al What do patients' efficacy and tolerability ratings of acute migraine medication
tell us? Cross-sectional data from the DMKG Headache Registry.
Cephalalgia. 2023;43:3331024231174855. PubMedAbstract available
STEINER TJ Classification of migraine and tension-type headache: A response to the proposals
of Olesen.
Cephalalgia. 2023;43:3331024231169240. PubMed
SUZUKI K, Suzuki S, Shiina T, Tatsumoto M, et al Effectiveness of three calcitonin gene-related peptide monoclonal antibodies for
migraine: A 12-month, single-center, observational real-world study in Japan.
Cephalalgia. 2023;43:3331024231177649. PubMedAbstract available
PARK CG, Na HY, Park DE, Kim HY, et al Altered interictal serum histamine and immunoglobulin E but unchanged tryptase
levels in individuals with episodic and chronic migraine.
Cephalalgia. 2023;43:3331024231178218. PubMedAbstract available
ABU-ARAFEH I, Hershey AD, Diener HC, Tassorelli C, et al Guidelines Update: Guidelines of the International Headache Society for
controlled trials of preventive treatment of migraine in children and
adolescents, 1st edition - An experience-based update.
Cephalalgia. 2023;43:3331024231178239. PubMedAbstract available
April 2023
GIRI S, Tronvik E, Linde M, Pedersen SA, et al Randomized controlled studies evaluating Topiramate, Botulinum toxin type A, and
mABs targeting CGRP in patients with chronic migraine and medication overuse
headache: A systematic review and meta-analysis.
Cephalalgia. 2023;43:3331024231156922. PubMedAbstract available
OLESEN J, Jensen RH The Global Campaign Against Headache and its future relation to IHS and WHO.
Cephalalgia. 2023;43:3331024231159625. PubMedAbstract available
HAGHDOOST F, Puledda F, Garcia-Azorin D, Huessler EM, et al Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of
migraine: A systematic review and network meta-analysis of phase 3 randomised
controlled trials.
Cephalalgia. 2023;43:3331024231159366. PubMedAbstract available
NIDDAM DM, Wu SW, Lai KL, Yang YY, et al An altered reward system characterizes chronic migraine with medication overuse
headache.
Cephalalgia. 2023;43:3331024231158088. PubMedAbstract available
ASAWAVICHIENJINDA T, Sathitratanacheewin S, Chokesuwattanaskul R "Wearing-off" efficacy of CGRP monoclonal antibodies for migraine prevention: A
meta-analysis of randomized controlled trials.
Cephalalgia. 2023;43:3331024231161261. PubMedAbstract available
IANNONE LF, Burgalassi A, Vigani G, Tabasso G, et al Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder
patients and implications for ineffectiveness criteria: A retrospective cohort
study.
Cephalalgia. 2023;43:3331024231160519. PubMedAbstract available
FAVONI V, Mascarella D, Giannini G, Bauleo S, et al Prevalence, natural history and dynamic nature of chronic headache and medication
overuse headache in Italy: The SPARTACUS study.
Cephalalgia. 2023;43:3331024231157677. PubMedAbstract available
ASHINA M, Roos C, Li LQ, Komori M, et al Long-term treatment with lasmiditan in patients with migraine: Results from the
open-label extension of the CENTURION randomized trial.
Cephalalgia. 2023;43:3331024231161745. PubMedAbstract available
ZHANG L, Zhou Y, Wang Y, Yang L, et al Inhibiting PAC1 receptor internalization and endosomal ERK pathway activation may
ameliorate hyperalgesia in a chronic migraine rat model.
Cephalalgia. 2023;43:3331024231163131. PubMedAbstract available
RUSSO CV, Sacca F, Braca S, Sansone M, et al Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of
vestibular migraine: A prospective observational cohort study.
Cephalalgia. 2023;43:3331024231161809. PubMedAbstract available
OLESEN J Classification of migraine and tension-type headache.
Cephalalgia. 2023;43:3331024221139238. PubMed
CROWE HM, Wesselink AK, Hatch EE, Wise LA, et al Migraine and risk of hypertensive disorders of pregnancy: A population-based
cohort study.
Cephalalgia. 2023;43:3331024231161746. PubMedAbstract available
SAKAI F, Igarashi H, Yokoyama M, Begasse de Dhaem O, et al Diagnosis, knowledge, perception, and productivity impact of headache education
and clinical evaluation program in the workplace at an information technology
company of more than 70,000 employees.
Cephalalgia. 2023;43:3331024231165682. PubMedAbstract available